1Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing [S]. Fifteenth Informational Supplement M100-S15. Wayne, PA, USA:Clinical and Laboratory Standards Institute, 2005.
5Fass RJ,Barhishan J, Ayerd LW,et al. Emergence bacterial to imipenem and ciprofloxcin in an university hospital[J]. J Antimicrob Chemother, 1995,36: 343-353.
二级参考文献9
1[1]Kobayashi H. Airway biofilm disease. Clinical manifestation and therapeutic possibilities using macrolides[J]. J Infect Chemother,1995,1(1):1-15.
2[2]Hoiby N, Doring G, Schiotz PO. The role of immunized complexes in the pathogenesis of bacterial infections[J]. Ann Rev Microbiol,1986, 40(1):29-53.
3[3]Pedersen SS, Esperwen F, Hoiby N,et al. Purification, characterization, and immunological cross-reactivity of alginates produced by mucoid Pseudomonas aeruginosa from patients with cystic fibrosis[J]. J Clin Microbiol,1989,27(4):691-699.
4[4]Ohatami H. Study on the pathogenetic role of alginate produced by mucoid Pseudomonas aerugiosa in diffuse panbronchiolitis[J]. J Jpn Infect Dis, 1995,69(5):553-567.
5[5]Romani L, Puccetti P, Bistoni F. Interleukin-12 in infectious diseases[J]. Clin Microbiol Rev, 1997,10(5): 611-636.
